Literature DB >> 19390996

Hypothyroid Graves' disease complicated with elephantiasis nostras verrucosa (ENV): a case report and review of the literature.

Kubilay Ukinç1, Miyase Bayraktar, Arzu Gedik.   

Abstract

Thyroid dermopathy is not a frequent feature of hyperthyroid Graves' disease, being present in less than 5% of the patients. Graves' disease has been shown to exist in euthyroid or hypothyroid forms in untreated patients. Here, we describe a case of hypothyroid Graves' disease with elephantiasis nostras verrucosa (ENV), which is an extreme form of thyroid dermopathy (TD). A 58-year-old female patient was admitted to the emergency department with somnolence, hypothermia, and bradycardia. Her mental status gradually worsened, resulting in a deep coma. She was intubated and followed in the intensive care unit, as she needed mechanical ventilatory assistance due to respiratory failure. She also had bilateral non-pitting edema, a cobblestone-like appearance, and hyperkeratotic greenish-brown-colored lesions in the pretibial and dorsal regions of the feet that were compatible with ENV. Hypothyroid Graves' disease is a very rare condition among autoimmune thyroid disorders, and ENV is an extremely rare form of TD. Here, we present a patient with hypothyroid Graves' disease and ENV.

Entities:  

Mesh:

Year:  2009        PMID: 19390996     DOI: 10.1007/s12020-009-9200-4

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  23 in total

1.  Detection, cellular localization, and modulation of heat shock proteins in cultured fibroblasts from patients with extrathyroidal manifestations of Graves' disease.

Authors:  A E Heufelder; B E Wenzel; C A Gorman; R S Bahn
Journal:  J Clin Endocrinol Metab       Date:  1991-10       Impact factor: 5.958

2.  Pretibial myxedema and high-dose intravenous immunoglobulin treatment.

Authors:  A Antonelli; A Navarranne; R Palla; B Alberti; A Saracino; C Mestre; P Roger; S Agostini; L Baschieri
Journal:  Thyroid       Date:  1994       Impact factor: 6.568

3.  Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease.

Authors:  B Rapoport; R Alsabeh; D Aftergood; S M McLachlan
Journal:  Thyroid       Date:  2000-08       Impact factor: 6.568

4.  TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema.

Authors:  W Stadlmayr; C Spitzweg; A M Bichlmair; A E Heufelder
Journal:  Thyroid       Date:  1997-02       Impact factor: 6.568

5.  Hypothyroid Graves' disease.

Authors:  J H Christy; R S Morse
Journal:  Am J Med       Date:  1977-02       Impact factor: 4.965

6.  Dermopathy of Graves disease (pretibial myxedema). Review of 150 cases.

Authors:  V Fatourechi; M Pajouhi; A F Fransway
Journal:  Medicine (Baltimore)       Date:  1994-01       Impact factor: 1.889

7.  Triad of exophthalmos, pretibial myxedema, and acropachy in a patient with Graves' disease.

Authors:  Christina K Anderson; O Fred Miller
Journal:  J Am Acad Dermatol       Date:  2003-06       Impact factor: 11.527

8.  Effect of plasmapheresis and steroid treatment on thyrotropin binding inhibitory immunoglobulins in a patient with exophthalmos and a patient with pretibial myxedema.

Authors:  N Kuzuya; L J DeGroot
Journal:  J Endocrinol Invest       Date:  1982 Nov-Dec       Impact factor: 4.256

9.  Thyroid growth-blocking antibodies in primary myxoedema.

Authors:  H A Drexhage; G F Bottazzo; L Bitensky; J Chayen; D Doniach
Journal:  Nature       Date:  1981-02-12       Impact factor: 49.962

10.  A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol.

Authors:  K Kasagi; J Konishi; K Arai; T Misaki; Y Iida; K Endo; K Torizuka
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

View more
  1 in total

1.  Elephantiasis nostras verrucosa: swelling with verrucose appearance of lower limbs.

Authors:  Fang-Yih Liaw; Ching-Fu Huang; Yu-Cheng Wu; Bai-Yao Wu
Journal:  Can Fam Physician       Date:  2012-10       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.